# Aclarion, Inc.: filings

ACON · Nasdaq · CIK 1635077 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acon.md) · [Financials](/companies/acon/financials.md) · [Filings](/companies/acon/filings.md) · [Insiders](/companies/acon/insiders.md)

## Reports and events: 112 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 64, 4 38, CORRESP 20, 10-Q 14, UPLOAD 14, S-1/A 13, 3 12, EFFECT 11, 424B3 9, DEF 14A 7, PRE 14A 7, S-1 7, D 6, 424B5 5, SC 13G 5, 10-K 4, 3/A 3, 424B4 3, S-3 3, SC 13G/A 3, 8-A12B 2, 8-K/A 2, DEFA14A 2, NT 10-Q 2, POS AM 2, S-8 2, SCHEDULE 13G 2, 10-K/A 1, 1-A 1, 1-A/A 1, 253G3 1, 4/A 1, CERT 1, D/A 1, DRS 1, NT 10-K 1, QUALIF 1, S-1MEF 1, S-3/A 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 09:00 ET | [10-Q](/filings/0001683168-26-006026.md) | Quarterly report, period 2026-06-30 | 0001683168-26-006026 |
| 2026-06-04 | 16:49 ET | [8-K](/filings/0001683168-26-004565.md) | 5.07 Shareholder vote results | 0001683168-26-004565 |
| 2026-05-13 | 16:30 ET | [10-Q](/filings/0001683168-26-003822.md) | Quarterly report, period 2026-03-31 | 0001683168-26-003822 |
| 2026-04-27 | 16:05 ET | [DEF 14A](/filings/0001683168-26-003236.md) | Proxy statement, period 2026-06-04 | 0001683168-26-003236 |
| 2026-04-22 | 09:00 ET | [8-K](/filings/0001683168-26-003124.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-003124 |
| 2026-03-19 | 16:15 ET | [8-K](/filings/0001683168-26-002024.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-002024 |
| 2026-03-18 | 16:57 ET | [10-K](/filings/0001683168-26-001986.md) | Annual report, period 2025-12-31 | 0001683168-26-001986 |
| 2026-01-13 | 09:00 ET | [8-K](/filings/0001683168-26-000241.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-000241 |
| 2026-01-09 | 09:03 ET | [8-K](/filings/0001683168-26-000168.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-26-000168 |
| 2025-11-12 | 06:20 ET | [10-Q](/filings/0001683168-25-008169.md) | Quarterly report, period 2025-09-30 | 0001683168-25-008169 |
| 2025-10-14 | 06:05 ET | [8-K](/filings/0001683168-25-007516.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-25-007516 |
| 2025-09-03 | 17:00 ET | [8-K](/filings/0001683168-25-006659.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-006659 |
| 2025-08-14 | 13:48 ET | [10-Q](/filings/0001683168-25-006126.md) | Quarterly report, period 2025-06-30 | 0001683168-25-006126 |
| 2025-07-21 | 16:03 ET | [8-K](/filings/0001683168-25-005246.md) | 5.07 Shareholder vote results | 0001683168-25-005246 |
| 2025-07-07 | 16:15 ET | [8-K](/filings/0001683168-25-004952.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-004952 |
| 2025-06-20 | 17:07 ET | [8-K](/filings/0001683168-25-004669.md) | 5.02 Departure or appointment of officers or directors | 0001683168-25-004669 |
| 2025-05-15 | 07:54 ET | [10-Q](/filings/0001683168-25-003594.md) | Quarterly report, period 2025-03-31 | 0001683168-25-003594 |
| 2025-05-13 | 20:27 ET | [DEF 14A](/filings/0001683168-25-003452.md) | Proxy statement, period 2025-07-07 | 0001683168-25-003452 |
| 2025-04-23 | 07:30 ET | [8-K](/filings/0001683168-25-002738.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-002738 |
| 2025-04-09 | 21:45 ET | [10-K](/filings/0001683168-25-002351.md) | Annual report, period 2024-12-31 | 0001683168-25-002351 |
| 2025-03-28 | 16:30 ET | [8-K](/filings/0001683168-25-001987.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-25-001987 |
| 2025-03-13 | 10:31 ET | [8-K](/filings/0001683168-25-001566.md) | 8.01 Other events | 0001683168-25-001566 |
| 2025-03-06 | 09:25 ET | [8-K](/filings/0001683168-25-001373.md) | 5.07 Shareholder vote results | 0001683168-25-001373 |
| 2025-02-28 | 16:03 ET | [8-K](/filings/0001683168-25-001288.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-001288 |
| 2025-02-03 | 08:17 ET | [DEF 14A](/filings/0001683168-25-000634.md) | Proxy statement, period 2025-02-28 | 0001683168-25-000634 |
| 2025-01-31 | 10:53 ET | [8-K](/filings/0001683168-25-000627.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-000627 |
| 2025-01-30 | 16:02 ET | [8-K](/filings/0001683168-25-000612.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-000612 |
| 2025-01-17 | 17:22 ET | [8-K](/filings/0001683168-25-000431.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-25-000431 |
| 2025-01-10 | 17:21 ET | [S-1/A](/filings/0001683168-25-000233.md) | Registration statement, amended | 0001683168-25-000233 |
| 2025-01-06 | 07:05 ET | [8-K](/filings/0001683168-25-000099.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-000099 |
| 2025-01-03 | 14:59 ET | [8-K](/filings/0001683168-25-000059.md) | 1.02 Termination of a material agreement | 0001683168-25-000059 |
| 2025-01-03 | 14:49 ET | [8-K](/filings/0001683168-25-000056.md) | 5.07 Shareholder vote results | 0001683168-25-000056 |
| 2024-12-26 | 17:19 ET | [S-1/A](/filings/0001683168-24-008988.md) | Registration statement, amended | 0001683168-24-008988 |
| 2024-12-11 | 06:01 ET | [S-1](/filings/0001683168-24-008624.md) | Registration statement | 0001683168-24-008624 |
| 2024-12-02 | 06:01 ET | [DEF 14A](/filings/0001683168-24-008449.md) | Proxy statement, period 2024-12-31 | 0001683168-24-008449 |
| 2024-11-27 | 16:03 ET | [8-K](/filings/0001683168-24-008424.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-24-008424 |
| 2024-11-14 | 13:03 ET | [10-Q](/filings/0001683168-24-008063.md) | Quarterly report, period 2024-09-30 | 0001683168-24-008063 |
| 2024-10-25 | 17:05 ET | [S-1](/filings/0001683168-24-007397.md) | Registration statement | 0001683168-24-007397 |
| 2024-10-11 | 16:20 ET | [8-K](/filings/0001683168-24-007100.md) | 3.01 Delisting notice | 0001683168-24-007100 |
| 2024-10-01 | 16:07 ET | [8-K](/filings/0001683168-24-006791.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-24-006791 |
| 2024-09-24 | 16:58 ET | [8-K](/filings/0001683168-24-006627.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-24-006627 |
| 2024-09-23 | 16:01 ET | [8-K](/filings/0001683168-24-006598.md) | 5.07 Shareholder vote results | 0001683168-24-006598 |
| 2024-08-29 | 16:01 ET | [8-K](/filings/0001683168-24-006107.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-24-006107 |
| 2024-08-26 | 16:02 ET | [DEF 14A](/filings/0001683168-24-006029.md) | Proxy statement, period 2024-09-23 | 0001683168-24-006029 |
| 2024-08-23 | 16:58 ET | [8-K](/filings/0001683168-24-006005.md) | 3.01 Delisting notice | 0001683168-24-006005 |
| 2024-08-16 | 16:56 ET | [8-K](/filings/0001683168-24-005844.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-24-005844 |
| 2024-08-14 | 15:34 ET | [10-Q](/filings/0001683168-24-005682.md) | Quarterly report, period 2024-06-30 | 0001683168-24-005682 |
| 2024-08-13 | 07:56 ET | [8-K/A](/filings/0001683168-24-005512.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-24-005512 |
| 2024-08-12 | 16:02 ET | [8-K](/filings/0001683168-24-005494.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-24-005494 |
| 2024-06-26 | 08:30 ET | [8-K](/filings/0001683168-24-004470.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-24-004470 |

Page 1 of 3. [Older](/companies/acon/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.